This inventor holds 1 USPTO granted patent. Top assignee: Rhone Merieux, Societe Anonyme. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Vladimir Zelnik: Innovator in Herpesvirus Research
Introduction
Vladimir Zelnik is a notable inventor based in Bratislava, Slovakia. He has made significant contributions to the field of virology, particularly in the study and transformation of herpesviruses. His innovative work has implications for vaccine development and genetic research.
Latest Patents
Zelnik holds a patent for "Herpesviruses transformed to express GD in vitro." This invention involves transforming herpesviruses that are naturally deficient in the gD gene to express it in vitro. The transformation is achieved through genetic recombination, which may include replacing the natural promoter with another or inserting an expression cassette containing gD and a promoter. The invention also pertains to viruses that incorporate a gene coding for an antigen of interest, the vaccines derived from these viruses, and improved culture methods. This work is particularly relevant to avian herpesviruses, such as Marek's disease virus (MDV) and varicella-zoster virus (VZV).
Career Highlights
Zelnik's career is marked by his dedication to advancing the understanding of herpesviruses and their applications in medicine. His work at Rhone Merieux, a prominent company in the field, has allowed him to collaborate with other experts and contribute to groundbreaking research.
Collaborations
Throughout his career, Zelnik has worked alongside notable colleagues, including Jean-Christophe Francis Audonnet and Raphael Jean Darteil. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Vladimir Zelnik's innovative work in herpesvirus research exemplifies the importance of scientific inquiry in developing new medical solutions. His contributions continue to influence the field and pave the way for future advancements.